| Model Number |
8DFEN |
| Medical Device Problem Codes |
Use of Device Problem (1670); Defective Component (2292); Manufacturing, Packaging or Shipping Problem (2975)
|
| Health Effect - Clinical Codes |
Dyspnea (1816); Low Oxygen Saturation (2477); Unintended Extubation (4564)
|
| Date of Event |
04/04/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
According to the reporter, intra-operatively, the cannulas are out of alignment and it was inserted for only 15 seconds.It could not be traced why there was a drop in spo2 when the oo2 speaker attachment was applied (phonate speaking valve for use with low-flow oxygen port). furthermore, it was determined that the patient experienced dyspnea.The patient was decannulated.
|
| |
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: a3, b5, d3(mfr name, street 1, mfr city, postal code), d4(expiration date, lot#), g3, h4 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
According to the reporter, intra-operatively, the cannulas are out of alignment and it was inserted for only 15 seconds.It could not be traced why there was a drop in spo2 when the o2 speaker attachment was applied (phonate speaking valve for use with low-flow oxygen port). it was noted that oxygen saturation did not improve even when the flow was increased to 10 liters o2.Immediate removal of the speaking valve was performed in the presence of the intensive care physician and an improvement of the condition was observed.During the subsequent examination, it was found that the fenestration of one of the internal ducts was displaced and an approximate 40% closure of the overlap presented itself.Furthermore, it was determined that the patient experienced dyspnea.The patient was decannulated.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic conducted an investigation based upon all information received.The device was not returned, but a photo was available for evaluation.Visual inspection noted there was a defective component.It was reported that there was an issue with the inner cannula interface.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Functional testing was performed by inserting the inner cannula into the outer cannula and it was observed the fenestrations between the cannulas are out of alignment.It was reported that there was an issue with the inner cannula interface.The reported issue was confirmed.The most likely cause was determined to be manufacturing related.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|